Helicos Files Suit Against PacBio

Xconomy Boston — 

Cambridge, MA-based Helicos Biosciences (NASDAQ: HLCS), the maker of gene sequencing instruments, said today it has filed a lawsuit accusing Menlo Park, CA-based Pacific Biosciences of patent infringement. Helicos says it was the first to invent and market the technology known as single molecule sequencing, and that PacBio’s subsequent technology violates Helicos patents that extend to as far as 2028. PacBio, which is seeking to push the frontiers of faster/cheaper gene sequencing, filed paperwork last month for an attempt to raise $200 million through an IPO.